Description
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Cas No. | 2159123-14-3 |
|---|---|
| Purity | ≥98% |
| Formula | C22H23F3N4O3 |
| Formula Wt. | 448.45 |
| IUPAC Name | (1S,2S,3S,5R)-3-[[6-(difluoromethyl)-5-fluoro-1,2,3,4-tetrahydroisoquinolin-8-yl]oxy]-5-(4-methylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol |
| Synonym | PF06939999; PRMT5-IN-3 |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Jensen-Pergakes K, Tatlock J, Maegley K, et al. SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance. Mol Cancer Ther. 2022 Jan;21(1):3-15. PMID 34737197
Alkaloid originally found in species of Aconitu...
Cyclohexanecarboxylic acid found in various pla...
Microtubule depolymerization inhibitor.
Stable salt form of hyperforin, a compound foun...
Calcium channel blocker.
Cap-dependent endonuclease inhibitor
Coumarin, more potent isomer; VKORC1 inhibitor....
Amino acid alcohol.
HDAC inhibitor, mammalian RNA splicing modulato...
TRPA1 agonist, xanthine oxidase inhibitor.
Thienylbutyl ITC analog.
Akt inhibitor.
p110δ PI3K inhibitor.
Serotonin/melatonin analog found in various pla...
Induces cardiomyogenic effects in pluripotent c...
Selective inhibitor of c-Met.
CDK inhibitor.
Endogenous RF-amide peptide, involved in nocice...
Mycotoxin produced by Alternaria; topoisomerase...
Electron carrier used to study dehydrogenase el...